Neuronetics financials
$2.36−7.63%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $149.2M | $74.9M | $71.3M | $65.2M | $55.3M | $49.2M | $62.7M | $52.8M |
| Gross profit | $72.3M | $54.2M | $51.7M | $49.7M | $43.7M | $37.7M | $47.3M | $40.3M |
| Gross margin | 48.5% | 72.3% | 72.5% | 76.3% | 78.9% | 76.5% | 75.4% | 76.4% |
| Operating income | -$31.4M | -$34.6M | -$30.6M | -$35.1M | -$27.6M | -$22.3M | -$26.9M | -$19.8M |
| Net income | -$39.0M | -$43.7M | -$30.2M | -$37.2M | -$31.2M | -$27.5M | -$29.0M | -$24.1M |
| Net margin | −26.1% | −58.4% | −42.3% | −57.0% | −56.4% | −55.7% | −46.4% | −45.7% |
| Diluted EPS | $-0.59 | $-1.38 | $-1.05 | $-1.38 | $-1.22 | $-1.46 | $-1.58 | $-2.69 |
| EBITDA | -$28.0M | -$32.5M | -$28.5M | -$33.5M | -$26.5M | -$21.4M | -$25.9M | -$19.0M |
| Operating cash flow | -$20.4M | -$31.0M | -$32.0M | -$30.7M | -$28.0M | -$28.4M | -$30.5M | -$20.5M |
| Free cash flow | -$21.2M | -$32.5M | -$34.4M | -$34.0M | -$30.3M | -$29.1M | -$31.3M | -$21.5M |
| Diluted shares | 66.0M | 31.7M | 28.7M | 26.9M | 25.5M | 18.8M | 18.4M | 8.9M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $28.1M | $18.5M | $59.7M | $70.3M | $94.1M | $49.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $65.8M | $55.2M | $59.3M | $36.0M | $35.3M | $34.6M |
| Total assets | $141.6M | $140.9M | $115.8M | $116.9M | $141.2M | $78.7M |
| Total liabilities | $115.3M | $109.1M | $81.6M | $59.8M | $56.0M | $53.2M |
| Shareholders' equity | $26.2M | $31.8M | $34.2M | $57.1M | $85.2M | $25.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology